FDA Adverse Event Injury Summary report: N

SYSTEM, APPENDAGE CLOSURE, LEFT ATRIAL

MDR report key: 22513219 · Received July 15, 2025

Report

Report Number
2124215-2025-46114
Event Type
Injury
Date Received
July 15, 2025
Date of Event
November 19, 2024
Report Date
July 15, 2025
Manufacturer
BOSTON SCIENTIFIC CORPORATION
Product Code
NGV
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IT
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

B3 DATE OF EVENT - ARTICLE PUBLISH DATE USED AS EVENT DATE IS UNKNOWN. D4 MODEL NUMBER, D4 LOT NUMBER, D4 EXPIRATION DATE, D4 UNIQUE IDENTIFIER (UDI) # ARE UNKNOWN AS THE INFORMATION WAS NOT PROVIDED IN THE LITERATURE ARTICLE. D6A IMPLANT DATE WAS REPORTED AS BETWEEN (B)(6) 2021 AND (B)(6) 2023.

Description of Event or Problem · 0

REPORTED VIA JOURNAL ARTICLE. IT WAS REPORTED THAT THERE WAS A THROMBUS. THIS STUDY WAS AIMED AT ASSESSING 1 YEAR CLINICAL AND TRANSESOPHAGEAL ECHOCARDIOGRAPHIC (TEE) OUTCOMES IN A CONSECUTIVE SERIES OF PATIENTS UNDERGOING LEFT ATRIAL APPENDAGE (LAA) CLOSURE WITH A SINGLE-SEAL (WATCHMAN FIRST GENERATION OR WATCHMAN FLX) OR DUAL- SEAL DEVICE (NON-BOSTON SCIENTIFIC DEVICE). RESULTS: BETWEEN JANUARY 2021 AND JANUARY 2023 47 PATIENTS WERE ENROLLED, WITH PAROXYSMAL, PERSISTENT OR PERMANENT NON VALVULAR ATRIAL FIBRILLATION, A CHA2DS2-VASC SCORE OF 3 AND A HAS-BLED SCORE OF 3, NOT ELIGIBLE FOR LONG-TERM ORAL ANTICOAGULATION. AT ONE (1) YEAR FOLLOW-UP, NO PATIENT REPORTED CLINICAL EVENTS. AT ONE (1) YEAR FOLLOW UP TEE, 1 PATIENT EXHIBITED A PERI-DEVICE LEAK LESS THAN 3MM, WITHOUT ANY CLINICAL EVENT. TWO PATIENTS EXHIBITED DEVICE- RELATED THROMBOSIS (1 WATCHMAN AND 1 NON-BOSTON SCIENT DEVICE). THESE PATIENTS UNDERWENT LONG-TERM IMAGING SURVEILLANCE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1572750 SYSTEM, APPENDAGE CLOSURE, LEFT ATRIAL NGV BOSTON SCIENTIFIC CORPORATION

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown Other